Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaud Didierlaurent

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Immunology|November 10, 2007
The impact of successive infections on the lung microenvironmentArnaud Didierlaurent, John Goulding, Tracy Hussell
European Journal of Immunology|February 3, 2006
Pathogen-specific TLR signaling in mucosa: mutual contribution of microbial TLR agonists and virulence factorsJean-Claude Sirard, Mariela Bayardo, Arnaud Didierlaurent
Trends in Microbiology|March 24, 2004
Dendritic cells: the host Achille's heel for mucosal pathogens?Florence Niedergang, Arnaud Didierlaurent, Jean-Pierre Kraehenbuhl, et al.
Annals of Medicine|March 20, 2025
Age-related changes in the immune system and challenges for the development of age-specific vaccinesT Mark Doherty, Birgit Weinberger, Arnaud Didierlaurent, et al.
Biochimica Et Biophysica Acta|March 24, 2009
Toll-like receptor 5- and lymphotoxin beta receptor-dependent epithelial Ccl20 expression involves the same NF-kappaB binding site but distinct NF-kappaB pathways and dynamicsJean-Claude Sirard, Arnaud Didierlaurent, Delphine Cayet, et al.
Vaccines|September 28, 2021
Pediatric COVID-19: Immunopathogenesis, Transmission and PreventionGeraldine Blanchard-Rohner, Arnaud Didierlaurent, Anne Tilmanne, et al.
Cellular Microbiology|March 19, 2002
How the gut senses its contentArnaud Didierlaurent, Jean-Claude Sirard, Jean-Pierre Kraehenbuhl, et al.
Nature Communications|January 7, 2026
Adjuvanted influenza vaccination increases pre-existing H5N1 cross-reactive antibodiesMariana Alcocer Bonifaz, Disha Bhavsar, Claire-Anne Siegrist, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 6, 2011
Development of an AS04-adjuvanted HPV vaccine with the adjuvant system approachNathalie Garçon, Sandra Morel, Arnaud Didierlaurent, et al.
European Journal of Immunology|June 5, 2003
Role of Toll-like receptors in costimulating cytotoxic T cell responsesKatrin Schwarz, Tazio Storni, Vania Manolova, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Immunology|November 10, 2007
The impact of successive infections on the lung microenvironmentArnaud Didierlaurent, John Goulding, Tracy Hussell
European Journal of Immunology|February 3, 2006
Pathogen-specific TLR signaling in mucosa: mutual contribution of microbial TLR agonists and virulence factorsJean-Claude Sirard, Mariela Bayardo, Arnaud Didierlaurent
Trends in Microbiology|March 24, 2004
Dendritic cells: the host Achille's heel for mucosal pathogens?Florence Niedergang, Arnaud Didierlaurent, Jean-Pierre Kraehenbuhl, et al.
Annals of Medicine|March 20, 2025
Age-related changes in the immune system and challenges for the development of age-specific vaccinesT Mark Doherty, Birgit Weinberger, Arnaud Didierlaurent, et al.
Biochimica Et Biophysica Acta|March 24, 2009
Toll-like receptor 5- and lymphotoxin beta receptor-dependent epithelial Ccl20 expression involves the same NF-kappaB binding site but distinct NF-kappaB pathways and dynamicsJean-Claude Sirard, Arnaud Didierlaurent, Delphine Cayet, et al.
Vaccines|September 28, 2021
Pediatric COVID-19: Immunopathogenesis, Transmission and PreventionGeraldine Blanchard-Rohner, Arnaud Didierlaurent, Anne Tilmanne, et al.
Cellular Microbiology|March 19, 2002
How the gut senses its contentArnaud Didierlaurent, Jean-Claude Sirard, Jean-Pierre Kraehenbuhl, et al.
Nature Communications|January 7, 2026
Adjuvanted influenza vaccination increases pre-existing H5N1 cross-reactive antibodiesMariana Alcocer Bonifaz, Disha Bhavsar, Claire-Anne Siegrist, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 6, 2011
Development of an AS04-adjuvanted HPV vaccine with the adjuvant system approachNathalie Garçon, Sandra Morel, Arnaud Didierlaurent, et al.
European Journal of Immunology|June 5, 2003
Role of Toll-like receptors in costimulating cytotoxic T cell responsesKatrin Schwarz, Tazio Storni, Vania Manolova, et al.
Pageof 3